{"organizations": [], "uuid": "271303c8bbe7cf51beec2e387eb755be6da1d376", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-moleculin-biotech-resale-by-sellin/brief-moleculin-biotech-resale-by-selling-shareholders-of-up-to-2-1-mln-shares-of-cos-common-stock-issuable-upon-exercise-of-outstanding-warrants-idUSFWN1RO0YZ", "country": "US", "domain_rank": 408, "title": "BRIEF-Moleculin Biotech Resale By Selling Shareholders Of Up To 2.1 Mln Shares Of Co's Common Stock Issuable Upon Exercise Of Outstanding Warrants", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-12T00:21:00.000+03:00", "replies_count": 0, "uuid": "271303c8bbe7cf51beec2e387eb755be6da1d376"}, "author": "", "url": "https://www.reuters.com/article/brief-moleculin-biotech-resale-by-sellin/brief-moleculin-biotech-resale-by-selling-shareholders-of-up-to-2-1-mln-shares-of-cos-common-stock-issuable-upon-exercise-of-outstanding-warrants-idUSFWN1RO0YZ", "ord_in_thread": 0, "title": "BRIEF-Moleculin Biotech Resale By Selling Shareholders Of Up To 2.1 Mln Shares Of Co's Common Stock Issuable Upon Exercise Of Outstanding Warrants", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-moleculin biotech resale by sell", "sentiment": "negative"}, {"name": "common stock issuable upon exercise of outstanding warrants reuters", "sentiment": "none"}, {"name": "min read    moleculin biotech inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 11 (Reuters) - Moleculin Biotech Inc:\n* RESALE BY SELLING SHAREHOLDERS OF UP TO 2.1 MILLION SHARES OF CO'S COMMON STOCK ISSUABLE UPON EXERCISE OF OUTSTANDING WARRANTS Source text: ( bit.ly/2IKussO ) Further company coverage:\n ", "external_links": [], "published": "2018-04-12T00:21:00.000+03:00", "crawled": "2018-04-12T00:43:03.010+03:00", "highlightTitle": ""}